FDA Delays Decision On Moderna Vaccine For Adolescents

FDA Delays Decision On Moderna Vaccine For Adolescents

Newsy

Published

Watch VideoU.S. regulators are delaying their decision on Moderna's COVID-19 vaccine for 12-to-17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.

The FDA told the company Friday evening that its review could last until January, Moderna said.

The company also said it will delay filing...

Full Article